A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

Immunotherapeutic approaches have substantially improved the treatment of patients with advanced malignancies. However, most ...

A group led by Prof. Horacio Cabral has discovered a new method to construct protein complex-based therapeutics.

Researchers sought to determine whether CAR-T therapy would be effective in patients with RRMM and light chain amyloidosis.

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting ...

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

Real-world outcomes of patients with relapsed/refractory multiple myeloma treated with the chimeric antigen receptor (CAR) ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

One woman and two men with severe autoimmune conditions have gone into remission after being treated with bioengineered and ...

Psoriasis is a multifactorial immune-mediated inflammatory disease. Its pathogenesis involves abnormal accumulation of neutrophils and T-cell related abnormalities. Pyroptosis is a type of regulated ...